Proteinuria: Its clinical importance and role in progressive renal disease

American Journal of Kidney Diseases

Volumn 35, Issue 4 SUPPL. 1, 2000, Pages

  Keane, William F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Albuminuria; Cardiovascular disease; Chronic renal issufficiency; Diabetes mellitus; Nondiabetic renal disease; Progressive renal disease; Proteinuria

Indexed keywords

ALBUMIN;

ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ESSENTIAL HYPERTENSION; HUMAN; KIDNEY DISEASE; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT;

EID: 0034034094     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70237-X     Document Type: Article

References (83)

1. JS Cameron The nephrotic syndrome: A historical review JS Cameron RJ Glassock The Nephrotic Syndrome 1988 Dekker New York, NY 3 56 chap 1
2. JS Cameron DR Turner CS Ogg C Chantler DG Williams The long-term prognosis of patients with focal segmental glomerulosclerosis Clin Nephrol 10 1978 213 218
3. G D'Amico Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis Survey of the recent literature Am J Kidney Dis 20 1992 315 323
4. M Wehrmann A Bohle H Held H Schumm H Kendziorra H Pressier Long-term prognosis of focal sclerosing glomerulonephritis: An analysis of 250 cases with particular regard to tubulointerstitial changes Clin Nephrol 33 1990 115 122
5. JP Hayslett LS Krassner KG Bensch M Kashgarian FH Epstein Progression of “lipoid nephrosis” to renal insufficiency N Engl J Med 281 1969 181 187
6. JS Cameron RJ Glassock Natural history and outcome of the nephrotic syndrome JS Cameron RJ Glassock The Nephrotic Syndrome. 1988 Dekker New York, NY 999 1033
7. CE Mogensen Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310 1984 356 360
8. JW Messent TG Elliot RG Hill RJ Jarrett H Keen GC Viberti Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three-year follow-up study Kidney Int 41 1992 836 839
9. RJ Jarrett GC Viberti A Argyropoulos RD Hill U Mahmud TJ Murrels Microalbuminuria predicts mortality in non-insulin-dependent diabetics Diabet Med 1 1984 17 19
10. A Schmitz M Vaeth Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A ten-year follow-up study of 503 patients Diabet Med 5 1988 126 134
11. VR Collins GK Dowse CF Finch PZ Zimmet AW Linnane Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru Diabetes 38 1989 1602 1610
12. LM Gerber C Shmukler MH Alderman Differences in urinary albumin excretion rate between normotensive and hypertensive white and non white subjects Arch Intern Med 152 1992 373 377
13. N Lokkegaard I Haupter TB Kristensen Microalbuminuria in obesity Scand J Urol Nephrol 26 1992 275 278
14. PH Bennett S Haffner BL Kasiske WF Keane CE Mogensen H-H Parving MW Steffes GE Striker Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation Am J Kidney Dis 25 1995 107 112
15. WB Kannel MJ Stampfer WP Castelli J Verter The prognostic significance of proteinuria: The Framingham study Am Heart J 108 1984 1347 1352
16. CJ Bulpitt DG Beevers A Butler E Coles D Hunt AD Munro-Faure RB Newson PW O'Riordan JC Petrie B Rajagopalan The survival of treated hypertensive patients and their causes of death: A report from the DHSS Hypertensive Care Computing Project (DHCCP) J Hypertens 4 1986 93 99
17. EM Damsgaard A Froland OD Jorgensen CE Mogensen Microalbuminuria as predictor of increased mortality in elderly people BMJ 300 1990 297 300
18. PH Winocour JO Harland JP Millar MF Laker KG Alberti Microalbuminuria and associated cardiovascular risk factors in the community Atherosclerosis 93 1992 71 81
19. G Cerasola S Cottone G Mule E Nardi MT Mangano G Andronico A Contorno M Li Vecchi P Gaglione F Renda G Piazza V Volpe A Lisi L Ferrara N Panepinto R Riccobene Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension J Hypertens 14 1996 915 920
20. RH Grimm KH Svendsen BL Kasiske WF Keane M Wahi Proteinuria is a risk factor for morality over 10 years of follow-up The MRFIT Research Group Kidney Int 52 suppl 1997 S-10 S-14
21. G Remuzzi T Bertani Pathophysiology of progressive nephropathies N Engl J Med 339 1998 1448 1456
22. P Ruggenenti A Perna G Gherardi G Garini C Zoccali M Salvadori F Scolari FP Schena G Remuzzi Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria Lancet 354 1999 359 364
23. P Ruggenenti A Perna G Gherardi F Gaspari R Benini G Remuzzi Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial Gruppo Italiano di Study Epidemiologici in Nefrologia (GISEN) Lancet 352 1998 1252 1256
24. P Rossing E Hommel UM Smidt H-H Parving Reduction in albuminuria predicts diminished progression in diabetic nephropathy Kidney Int 45 suppl 1994 S145 S149
25. JC Peterson S Adler JM Burkart T Greene LA Hebert LG Hunsicker AJ King S Klahr SG Massry JL Seifter Modification of Diet in Renal Disease MDRD Study Group Blood pressure control, proteinuria and the progression of renal disease Ann Intern Med 123 1995 754 762
26. AA Eddy Interstitial nephritis incued by protein-overload proteinuria Am J Pathol 135 1989 719 733
27. A Benigni C Zoja G Remuzzi The renal toxicity of sustained glomerular protein traffic Lab Invest 73 1995 461 468
28. AA Eddy Molecular insights into renal interstitial fibrosis J Am Soc Nephrol 7 1996 2495 2508
29. WF Keane G Eknoyan Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation Am J Kidney Dis 33 1999 1004 1010
30. S Bianchi R Bigazzi VM Campese Microalbuminuria in essential hypertension: Significance, pathophysiology and therapeutic implications Am J Kidney Dis 34 1999 973 995
31. B Agrawal A Berger K Wolf FC Luft Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension J Hypertens 14 1996 223 228
32. S Bianchi R Bigazzi G Baldari G Sgherri VM Campese Diurnal variation of blood pressure and microalbuminuria in essential hypertension Am J Hypertens 7 1994 23 29
33. S Equiluz-Bruck C Schnack HP Kopp G Schernthaner Non dipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus Am J Hypertens 9 1996 1139 1143
34. PL Poulsen KW Hansen CE Mogensen Ambulatory blood pressure in the transition from normo to microalbuminuria A longitudinal study in IDDM patients Diabetes 43 1994 1248 1253
35. KR Tuttle ME Puhlman SK Cooney R Short Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study Am J Kidney Dis 34 1999 918 925
36. K Pyörälä TR Pedersen J Kjekshus O Faergeman AG Olsson G Thorgeirsson Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620
37. JF Plehn BR Davis FM Sacks JL Rouleau MA Pfeffer V Bernstein TE Cuddy LA Moye LB Piller J Rutherford LM Simpson E Braunwald Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study The Care Investigators Circulation 19 1999 216 223
38. T Bertani F Cutillo C Zoja M Broggini G Remuzzi Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy Kidney Int 30 1986 488 496
39. AA Eddy CM Giachelli Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria Kidney Int 47 1995 1546 1557
40. WM Deen BD Myers BM Brenner The glomerular barrier to macromolecules: Theoretical and experimental considerations BM Brenner JH Stein Nephrotic Syndrome Vol 9 1982 Churchill Livingstone New York, NY 1 29 chap 1. Contemporary Issues in Nephrology
41. R Zatz BR Dunn TW Meyer S Anderson HG Rennke BM Brenner Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension J Clin Invest 77 1986 1925 1930
42. MP Bohrer WM Deen CR Robertson BM Brenner Mechanisms of angiotensin II-induced proteinuria in the rat Am J Physiol 233 1977 F13 F21
43. A Remuzzi S Puntorieri C Battaglia T Bertani G Remuzzi Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat J Clin Invest 85 1990 541 549
44. S Anderson TW Meyer HG Rennke BM Brenner Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass J Clin Invest 76 1985 612 619
45. S Anderson HG Rennke BM Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
46. S Anderson HG Rennke DL Garcia BM Brenner Short and long term effects of antihypertensive therapy in the diabetic rat Kidney Int 36 1989 526 536
47. BJ Tucker R Rasch RC Blantz Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats J Clin Invest 92 1993 686 694
48. C Zoja XH Liu M Abbate D Corna EL Schiffrin G Remuzzi A Benigni Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy Exp Nephrol 6 1998 121 131
49. M Abbate C Zoja D Carla M Capitanio T Bertani G Remuzzi In progressive nephropathies overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation J Am Soc Nephrol 9 1998 1213 1224
50. Y Wang J Chen L Chen Y-C Tay GK Rangan DC Harris Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein J Am Soc Nephrol 8 1997 1537 1545
51. S Orisio A Benigni I Bruzzi D Corna N Perico C Zoja L Benatti G Remuzzi Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression Kidney Int 43 1993 354 358
52. B Hocher C Thone-Reineke P Rohmeiss F Schmager T Slowinski V Burst F Siegmund T Quertermous C Bauer HH Neumayer WD Schleuning F Theuring Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension J Clin Invest 99 1997 1380 1389
53. C Zoja M Morigi M Figliuzzi I Bruzzi SD Oldroyd A Benigni P Ronco G Remuzzi Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins Am J Kidney Dis 26 1995 934 941
54. A Nomura Y Morita S Maruyama N Hotta M Nadai L Wang T Hasegawa S Matsuo Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis Am J Pathol 151 1997 539 547
55. L Biancone S David V Della Pietra G Montrucchio V Cambi G Carmussi Alternative pathway activation of complement by cultured human proximal tubular epithelial cells Kidney Int 45 1994 451 460
56. C Zoja R Donadelli S Colleoni M Figliuzzi S Bonazzola M Morigi G Remuzzi Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB Kidney Int 53 1998 1608 1615
57. PJ Barnes M: Karin Nuclear factor-kB A pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1997 1066 1071
58. ZA Massy C Guijarro MP O'Donnell Y Kim CE Kashtan J Egido BL Kasiske WF Keane The central role of nuclear factor-kB in mesangial cell activation Kidney Int 56 suppl 1999 S-76 S-79
59. P Rossing E Hommel UM Smidt HH Parving Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients Diabetes 42 1993 715 719
60. H Schmitt V Calvalcanti de Oliveira A Bohle Tubulo-interstitial alterations in type I membranoproliferative flomerulonephritis: An investigation of 259 cases Pathol Res Pract 182 1987 6 10
61. A Bohle M Wehrmann O Bogenschutz C Batz CA Muller GA Muller The pathogenesis of chronic renal failure in diabetic nephropathy: Investigation of 488 cases of diabetic glomerulosclerosis Pathol Res Pract 187 1991 251 259
62. ZA Massy C Guijarro BL Kasiske Clinical predictors of chronic renal allograft rejection Kidney Int 48 1995 S-85 S-88
63. S Klahr AS Levey GJ Beck AW Caggiula L Hunsicker JW Kusek G Striker The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease Modification of Diet in Renal Disease Study Group N Engl J Med 330 1994 877 884
64. JA Breyer RP Bain JK Evans NS Nahman EJ Lewis M Cooper J McGill T Berl Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy The Collaborative Study Group Kidney Int 50 1996 1651 1658
65. P Ruggenenti F Gaspari A Perna G Remuzzi Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes BMJ 316 1998 504 509
66. J Ahmad MA Siddiqui H Ahmad Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria Diabetes Care 20 1997 1576 1581
67. GC Viberti CE Mogensen LC Groop JF Pauls Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria European Microalbuminuria Captopril Study Group JAMA 271 1994 275 279
68. O Wirta A Pasternack J Mustonen H Oksa T Koivula H Helin Albumin excretion rate and its relation to kidney disease in non-insulin-dependent diabetes mellitus J Intern Med 237 1995 367 373
69. CE Mogensen CK Christensen Predicting diabetic nephropathy in insulin-dependent patients N Engl J Med 311 1984 89 93
70. H-H Parving B Oxenboll PA Svendsen JS Christiansen AR Andersen Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion Acta Endocrinol 100 1982 550 555
71. GC Viberti RD Hill RJ Jarrett A Argyropoulos U Mahmud H Keen Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 1 1982 1430 1432
72. R Bigazzi S Bianchi D Baldari VM Campese Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension J Hypertens 16 1998 1325 1333
73. RE Schmieder R Veelken CD Gatzka H Ruddle H Schachinger Predictors for hypertensive nephropathy: results of seven years of follow-up in essential hypertension J Hypertens 13 1994 357 365
74. LM Ruilope C Campo F Rodriguez-Artalejo V Lahera R Garcia Robles JL Rodicio Blood pressure and renal function: Therapeutic implications J Hypertens 14 1996 1259 1263
75. A Martinez-Vea C Gutierrez A Bardaji R Pastor C Garcìa C Peralta C Richart JA Oliver Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease Scand J Urol Nephrol 32 1998 356 359
76. G Maschio D Alberti G Janin F Locatelli JFE Mann M Motolese C Ponticelli E Ritz P Zucchelli Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
77. P Ruggenenti A Perna L Mosconi M Matalone R Pisoni F Gaspari G Remuzzi Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies The “Gruppo Italiano dei Studyi Epidemiologici in Nefrologia” (GISEN) Kidney Int 63 suppl 1997 S-54 S-57
78. Gruppo Italiano di Studi Epidemiologici in Nefrologia Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
79. FH Wapstra G Navis PE de Jong D de Zeeuw Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease Exp Nephrol 4 1996 47 52
80. EJ Lewis LG Hunsicker RP Bain RD Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy The Collaborative Study Group N Engl J Med 329 1993 1456 1462
81. JM Stephenson JH Fuller GC Viberti AK Sjolie R Navalesi Blood pressure, retinopathy and urinary albumin excretion in IDDM: The EURODIAB IDDM Complications Study Diabetologia 38 1995 599 603
82. P Gaede P Vedel H-H Parving O Pedersen Intensified multifactorial intervention in patients with type 2 diabeetes mellitus and microalbuminuria: The Steno type 2 randomised study Lancet 353 1999 617 622
83. FS Nielsen P Rossing MA Gall P Skott UM Smidt H-H Parving Long term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy Diabetes 46 1997 1182 1188